Acquisition-Related Amortization and Remeasurement - Additional Information (Details) - License Agreement [Member] $ in Millions	Apr. 07, 2021 USD ($)
Research And Development Arrangement Contract To Perform For Others [Line Items]
Contingent Payment Upon Reaching FDA Milestone	$ 4.0
Amount Recieved In Second Quater	$ 0.5

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

No definition available.

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration